CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells

被引:0
|
作者
Jung, In-Young
Kim, Yoon-Young
Yu, Ho-Sung
Kim, Seokjoong
Thon, Jonathan N.
Lee, Jungmin
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3182
引用
收藏
页数:2
相关论文
共 50 条
  • [41] DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells
    Zhao, Ruocong
    Cheng, Lin
    Jiang, Zhiwu
    Wei, Xinru
    Li, Baiheng
    Wu, Qiting
    Wang, Suna
    Lin, Simiao
    Long, Youguo
    Zhang, Xuchao
    Wu, Yilong
    Du, Xin
    Pei, Duanqing
    Liu, Pentao
    Li, Yangqiu
    Cui, Shuzhong
    Yao, Yao
    Li, Peng
    ONCOIMMUNOLOGY, 2019, 8 (01):
  • [42] Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cells
    Kaeuferle, Theresa
    Stief, Tanja A.
    Canzar, Stefan
    Kutlu, Nayad N.
    Willier, Semjon
    Stenger, Dana
    Ferrada-Ernst, Paulina
    Habjan, Nicola
    Peters, Annika E.
    Busch, Dirk H.
    Feuchtinger, Tobias
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (01)
  • [43] Anti-HLA-G antigen receptor T-cells exhibit potent anti-tumor effects against human solid tumors
    Epstein, Alan
    Kouhi, Aida
    Kouhi, Aida
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [44] CRISPR/Cas9-mediated Gene Knockout Followed by Negative Selection Leads to a Complete TCR Depletion in orthoCAR19 T Cells
    Zhang, Qian
    Yang, Jingyi
    Manoharan, Eric Nigel Ebenezer Anand
    Yu, Alvin B.
    Milone, Michael C.
    BIO-PROTOCOL, 2022, 12 (15):
  • [45] Chimeric antigen receptor T cells targeting primary CNS lymphoma: Visualizing the anti-tumor response in vivo
    Mulazzani, Matthias
    Frassle, Simon
    Buchholz, Veit
    Straube, Andreas
    Busch, Dirk
    von Baumgarten, Louisa
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [46] Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
    Ohno, Masasuke
    Ohkuri, Takayuki
    Kosaka, Akemi
    Tanahashi, Kuniaki
    June, Carl H.
    Natsume, Atsushi
    Okada, Hideho
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2013, 1
  • [47] Novel Pathogenic Mechanisms of Hypophosphatasia: Analysis of ALPL-Knockout Human iPS Cells Generated by CRISPR/Cas9-Mediated Gene Ablation
    Yamazaki, Miwa
    Ueta, Ayu
    Nakanishi, Tatsuro
    Tachikawa, Kanako
    Kawai, Masanobu
    Ozono, Keiichi
    Michigami, Toshimi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 121 - 121
  • [48] CRISPR/Cas9-Mediated Gene Knockout Reveals the Mucin Regulating Function of CC16 in Human Distal Airway Epithelial Cells
    Kimura, H.
    Francisco, D.
    Conway, M.
    Molzahn, A.
    Schaunaman, N.
    Chu, H.
    Kraft, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] CRISPR/Cas9-mediated knockout of PLK4 results in antiproliferative response in human epidermoid carcinoma cells in vitro and in implanted xenografts
    Ndiaye, Mary A.
    Garvey, Debra R.
    Chhabra, Gagan
    Singh, Chandra K.
    Ahmad, Nihal
    CANCER RESEARCH, 2022, 82 (12)
  • [50] CRISPR/Cas9-mediated gene knockout reveals a guardian role of NF-κB/RelA in maintaining the homeostasis of human vascular cells
    Ping Wang
    Zunpeng Liu
    Xiaoqian Zhang
    Jingyi Li
    Liang Sun
    Zhenyu Ju
    Jian Li
    Piu Chan
    GuangHui Liu
    Weiqi Zhang
    Moshi Song
    Jing Qu
    Protein & Cell, 2018, 9 (11) : 945 - 968